Literature DB >> 19224143

Monitoring of tumor oxygenation changes in head-and-neck carcinoma patients breathing a hyperoxic hypercapnic gas mixture with a noninvasive MRI technique.

Markus Kotas1, Peter Schmitt, Peter M Jakob, Michael Flentje.   

Abstract

PURPOSE: : To implement and evaluate a noninvasive functional MRI technique for measuring tumor tissue oxygenation changes in head-and-neck carcinoma patients. PATIENTS AND METHODS: : Tissue oxygenation changes were determined quantitatively in 13 patients with head-and-neck cancer. The MR examinations were performed on a clinical MR scanner at 1.5 T. Different breathing gases (air, 2% CO(2) and 98% O(2), 100% oxygen) were administered to induce oxygenation changes. A multigradient echo sequence was used for quantification of the apparent transverse relaxation time T2*.
RESULTS: : Pixel-by-pixel analysis of the T2* values in tumors showed a shift toward higher values corresponding to oxygenation increase and correlated with a median shift toward positive values in the DeltaT2* fraction under carbogen and oxygen breathing in most but not all patients. A slightly pronounced T2* increase breathing oxygen compared with 2% CO(2)/98% O(2) was found. Furthermore, a statistically significant difference in the heterogeneity of oxygenation changes induced by oxygen or 2% CO(2)/ 98% O(2) breathing was seen.
CONCLUSION: : Measurement of oxygenation changes in head-and-neck tumor patients is feasible by the presented MRI technique. Tumor oxygenation and oxygenation changes were heterogeneous among the investigated patients. To the authors' knowledge, they are the first to describe a statistically significant difference in the heterogeneity of oxygenation changes induced by oxygen or 2% CO(2)/98% O(2) breathing using a noninvasive MRI technique.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19224143     DOI: 10.1007/s00066-009-1870-6

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN: 0179-7158            Impact factor:   3.621


  10 in total

1.  Verification of IMRT: techniques and problems.

Authors:  Ludwig Bogner; Josef Scherer; Marius Treutwein; Matthias Hartmann; Franz Gum; Axel Amediek
Journal:  Strahlenther Onkol       Date:  2004-06       Impact factor: 3.621

2.  HIS/RIS/PACS integration: getting to the gold standard.

Authors:  Stephen S Boochever
Journal:  Radiol Manage       Date:  2004 May-Jun

Review 3.  Intensity-modulated radiation therapy (IMRT) with different combinations of treatment-planning systems and linacs: issues and how to detect them.

Authors:  Barbara Dobler; Friedlieb Lorenz; Hansjörg Wertz; Martin Polednik; Dirk Wolff; Volker Steil; Frank Lohr; Frederik Wenz
Journal:  Strahlenther Onkol       Date:  2006-08       Impact factor: 3.621

4.  Enterprise imaging and multi-departmental PACS.

Authors:  Björn Bergh
Journal:  Eur Radiol       Date:  2006-08-16       Impact factor: 5.315

5.  [Dosimetric impact of image-guided translational isocenter correction for 3-D conformal radiotherapy of the prostate].

Authors:  Hansjoerg Wertz; Frank Lohr; Barbara Dobler; Sabine Mai; Frederik Wenz
Journal:  Strahlenther Onkol       Date:  2007-04       Impact factor: 3.621

6.  Frameless stereotactic radiosurgery of a solitary liver metastasis using active breathing control and stereotactic ultrasound.

Authors:  Judit Boda-Heggemann; Cornelia Walter; Sabine Mai; Barbara Dobler; Dietmar Dinter; Frederik Wenz; Frank Lohr
Journal:  Strahlenther Onkol       Date:  2006-04       Impact factor: 3.621

Review 7.  Image-guidance for stereotactic body radiation therapy.

Authors:  Martin Fuss; Judit Boda-Heggemann; Nikos Papanikolau; Bill J Salter
Journal:  Med Dosim       Date:  2007       Impact factor: 1.482

8.  Local high-dose radiotherapy and sparing of normal tissue using intensity-modulated radiotherapy (IMRT) for mucosal melanoma of the nasal cavity and paranasal sinuses.

Authors:  Stephanie E Combs; Stephan Konkel; Christoph Thilmann; Jürgen Debus; Daniela Schulz-Ertner
Journal:  Strahlenther Onkol       Date:  2007-02       Impact factor: 3.621

9.  Helical tomotherapy as a new treatment technique for whole abdominal irradiation.

Authors:  Nathalie Rochet; Florian Sterzing; Alexandra Jensen; Julien Dinkel; Klaus Herfarth; Kai Schubert; Michael Eichbaum; Andreas Schneeweiss; Christof Sohn; Juergen Debus; Wolfgang Harms
Journal:  Strahlenther Onkol       Date:  2008-03       Impact factor: 3.621

10.  Precision of image-guided radiotherapy (IGRT) in six degrees of freedom and limitations in clinical practice.

Authors:  Matthias Guckenberger; Juergen Meyer; Juergen Wilbert; Kurt Baier; Otto Sauer; Michael Flentje
Journal:  Strahlenther Onkol       Date:  2007-06       Impact factor: 3.621

  10 in total
  9 in total

1.  Simultaneous integrated boost intensity-modulated radiotherapy (SIB‑IMRT) in nasopharyngeal cancer.

Authors:  Evangelia Peponi; Christoph Glanzmann; Guntram Kunz; Christoph Renner; Katja Tomuschat; Gabriela Studer
Journal:  Strahlenther Onkol       Date:  2010-02-22       Impact factor: 3.621

2.  Clinical comparison of dose calculation using the enhanced collapsed cone algorithm vs. a new Monte Carlo algorithm.

Authors:  Irina Fotina; Gabriele Kragl; Bernhard Kroupa; Robert Trausmuth; Dietmar Georg
Journal:  Strahlenther Onkol       Date:  2011-06-27       Impact factor: 3.621

Review 3.  The emerging potential of magnetic resonance imaging in personalizing radiotherapy for head and neck cancer: an oncologist's perspective.

Authors:  Kee H Wong; Rafal Panek; Shreerang A Bhide; Christopher M Nutting; Kevin J Harrington; Katie L Newbold
Journal:  Br J Radiol       Date:  2017-03       Impact factor: 3.039

Review 4.  Functional magnetic resonance imaging techniques and their development for radiation therapy planning and monitoring in the head and neck cancers.

Authors:  Jing Yuan; Gladys Lo; Ann D King
Journal:  Quant Imaging Med Surg       Date:  2016-08

5.  Cystatin C - a fast and reliable biomarker for glomerular filtration rate in head and neck cancer patients.

Authors:  Edwin Bölke; Gisela Schieren; Stephan Gripp; Gerald Steinbach; Matthias Peiper; Klaus Orth; Christiane Matuschek; Maximilian Pelzer; Guido Lammering; Ruud Houben; Christina Antke; Lars Christian Rump; Rodrigo Mota; Peter Arne Gerber; Patrick Schuler; Thomas K Hoffmann; Ethelyn Rusnak; Derik Hermsen; Wilfried Budach
Journal:  Strahlenther Onkol       Date:  2011-02-24       Impact factor: 3.621

6.  Quantitative assessment of hypoxia subtypes in microcirculatory supply units of malignant tumors using (immuno-)fluorescence techniques.

Authors:  Constantin-Alin Maftei; Christine Bayer; Kuangyu Shi; Sabrina T Astner; Peter Vaupel
Journal:  Strahlenther Onkol       Date:  2011-03-24       Impact factor: 3.621

7.  Correlation of pretreatment polarographically measured oxygen pressures with quantified contrast-enhanced power doppler ultrasonography in spontaneous canine tumors and their impact on outcome after radiation therapy.

Authors:  Carla Rohrer Bley; Dagmar Laluhova; Malgorzata Roos; Barbara Kaser-Hotz; Stefanie Ohlerth
Journal:  Strahlenther Onkol       Date:  2009-11-10       Impact factor: 3.621

Review 8.  Functional MRI for the prediction of treatment response in head and neck squamous cell carcinoma: potential and limitations.

Authors:  Ann D King; Harriet C Thoeny
Journal:  Cancer Imaging       Date:  2016-08-19       Impact factor: 3.909

9.  Repeatability and sensitivity of T2* measurements in patients with head and neck squamous cell carcinoma at 3T.

Authors:  Rafal Panek; Liam Welsh; Alex Dunlop; Kee H Wong; Angela M Riddell; Dow-Mu Koh; Maria A Schmidt; Simon Doran; Dualta Mcquaid; Georgina Hopkinson; Cheryl Richardson; Christopher M Nutting; Shreerang A Bhide; Kevin J Harrington; Simon P Robinson; Kate L Newbold; Martin O Leach
Journal:  J Magn Reson Imaging       Date:  2016-01-22       Impact factor: 4.813

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.